| Tag | Content |
|---|
EnhancerAtlas ID | HS047-12751 |
Organism | Homo sapiens |
Tissue/cell | Fetal_placenta |
Coordinate | chr16:28934920-28935720 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| STAT3 | MA0144.2 | chr16:28935374-28935385 | TTTCCCAGAAG | - | 6.62 | | Stat4 | MA0518.1 | chr16:28935371-28935385 | CTATTTCCCAGAAG | - | 6.16 | | Tcf12 | MA0521.1 | chr16:28934982-28934993 | CAGCAGCTGTT | - | 6.32 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10806 | chr16:28934105-28937640 | CD19_Primary | | SE_11724 | chr16:28932064-28938989 | CD20 | | SE_54362 | chr16:28934039-28937660 | Spleen | | SE_62078 | chr16:28933981-28957654 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | ATTGCACAGG CAGGTGGATC CTGAAATGTG GGAAATACAG CCCCAGAGAA GTCTCCAGCC 60
ACCAGCAGCT GTTAGAAAGG GAAATCGCAT GTTGGGAAGG GAATTTTAGG AAGTTTACTC 120
TGGAAGCCAA TGTCAAGGCC ACACTATAGA GGAAGATCTG TGAGAAGGTT GGGACAAAAG 180
TCCAGGAGAG AGTTGACGAG AGCCCCACCG CAGCAGGGGC ATAGCAGCGG GGGCAGCTCT 240
GACATCTGTT TCAGAGTCTC TGGCTTCTGC TAGAGGAAGG AGAGTAGAAA ACAGGATCAG 300
CAGCTGGGGC GTCTGGGGCC AGAGGACCAA GTACAAAGAA CGTGGGGCGG AGGTGGGGAA 360
GCTGGTGCAT GGCGTGGGGT GGAGGGGGGA GTGTCTGGGG AAGGCTAGAG AGCAGAGCAT 420
TAGACTCACA GAGACTGGGC CAGGGCTGAT TCTATTTCCC AGAAGTCCAG ACTAAAATGA 480
GGTTGGTTTG GGGAACTGAG AAGTTTCTCG CCCATCTTCA GGGTTGATCA ATCATCAGTG 540
AGGGACAAGA AATGACATGG GACAAGGCAA CAGATAGAAG CTGGGAGCTA AACTTAGCTA 600
TAACTGACAG AGCTGCTGCT ATCACATGGA GGGCCTCTAT GCAAATTTTA AAAGGGCGGC 660
CCTTCCTCTG GGCCATAGGC ATGCCCTGTG CCAGGCAGCC CTGCTAACCT ATCCCATAGC 720
TTATCTGTGC CCCCAATCCC TTTCTCGTCA TGCACTCCCC AGTATGGGGT TGATGGGGAG 780
TCTAGGTGAG TCCCGCGTCT 800
|
